Impact of Ticagrelor vs. Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Left Main Percutaneous Coronary Intervention

Abstract. Objective:. There is limited evidence regarding the choice of P2Y12 receptor inhibitors as a component of dual antiplatelet therapy in patients with left main (LM) disease undergoing percutaneous coronary intervention (PCI). This study aimed to evaluate long-term clinical outcomes of tica...

Full description

Bibliographic Details
Published in:Cardiology Discovery
Main Authors: Miaohan Qiu, Xuehan Zhi, Haiwei Liu, Zhenyang Liang, Bin Wang, Kai Xu, Shaoyi Guan, Geng Wang, Xiaozeng Wang, Yingyan Ma, Quanmin Jing, Xiaoxia Fu
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2025-03-01
Online Access:http://journals.lww.com/10.1097/CD9.0000000000000134